pyruvaldehyde has been researched along with Arteriosclerosis, Coronary in 4 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary atherosclerosis was assessed by computed tomography coronary angiography or intravascular ultrasound." | 1.62 | Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes. ( Bech Holte, K; Bengtsson, E; Hanssen, KF; Julsrud Berg, T; Nilsson, J; Svanteson, M; Sveen, KA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sveen, KA | 1 |
| Bech Holte, K | 1 |
| Svanteson, M | 1 |
| Hanssen, KF | 1 |
| Nilsson, J | 2 |
| Bengtsson, E | 2 |
| Julsrud Berg, T | 1 |
| Lankin, V | 1 |
| Konovalova, G | 1 |
| Tikhaze, A | 1 |
| Shumaev, K | 1 |
| Kumskova, E | 1 |
| Viigimaa, M | 1 |
| Monnier, VM | 1 |
| Sun, W | 1 |
| Gao, X | 1 |
| Sell, DR | 1 |
| Cleary, PA | 1 |
| Lachin, JM | 1 |
| Genuth, S | 1 |
| Engelbertsen, D | 1 |
| Anand, DV | 1 |
| Fredrikson, GN | 1 |
| Hopkins, D | 1 |
| Corder, R | 1 |
| Shah, PK | 1 |
| Lahiri, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diabetes Control and Complications Trial (DCCT)[NCT00360815] | 1,441 participants | Interventional | 1983-08-31 | Completed | |||
| Epidemiology of Diabetes Interventions and Complications (EDIC)[NCT00360893] | 1,441 participants (Actual) | Observational | 1994-04-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pyruvaldehyde and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery | 2015 |
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery | 2015 |
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery | 2015 |
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery | 2015 |
3 other studies available for pyruvaldehyde and Arteriosclerosis, Coronary